Cargando…

Beneficial Effect of Left Ventricular Remodeling after Early Change of Sacubitril/Valsartan in Patients with Nonischemic Dilated Cardiomyopathy

Background and Objectives: Evidence for effectiveness of early change from angiotensin II receptor blockers (ARBs) or angiotensin-converting enzyme inhibitors (ACEIs) to sacubitril/valsartan is lacking. We aimed to investigate whether early changes to sacubitril/valsartan could improve outcomes in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyue-Mee, Kim, Kyung-Hee, Park, Jin-Sik, Oh, Byung-Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146255/ https://www.ncbi.nlm.nih.gov/pubmed/33922990 http://dx.doi.org/10.3390/medicina57050416

Ejemplares similares

T1 Map-Based Radiomics for Prediction of Left Ventricular Reverse Remodeling in Patients With Nonischemic Dilated Cardiomyopathy
por: Chang, Suyon, et al.
Publicado: (2023)

Mechanistic Efficacy of Sacubitril/Valsartan in Ischemic Versus Nonischemic Heart Failure
por: Mohebi, Reza, et al.
Publicado: (2023)

Effect of sacubitril/valsartan or valsartan on ventricular remodeling and myocardial fibrosis in perimenopausal women with hypertension
por: Chen, Jianshu, et al.
Publicado: (2023)

Data on effect of Sacubitril/valsartan on cardiac Remodelling in diabetic Cardiomyopathy rats
por: Ai, Jiao, et al.
Publicado: (2021)

Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
por: Mustafa, Nor Hidayah, et al.
Publicado: (2022)

Ventricular arrhythmias in nonischemic cardiomyopathy
por: Chung, Fa‐Po, et al.
Publicado: (2018)

Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control
por: Seferovic, Jelena P., et al.
Publicado: (2020)

Left Ventricular Noncompaction: A Rare Case of Nonischemic Cardiomyopathy
por: Tian, Julia, et al.
Publicado: (2019)

Left Ventricular Global Longitudinal Strain as a Predictor for Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy
por: Jung, In Hyun, et al.
Publicado: (2020)

Antifailure Therapy Including Spironolactone Improves Left Ventricular Energy Supply‐Demand Relations in Nonischemic Dilated Cardiomyopathy
por: Bell, Susan P., et al.
Publicado: (2014)

Effect of add-on sacubitril/valsartan on the left ventricular hypertrophy of a patient with hypertension
por: Imamura, Teruhiko, et al.
Publicado: (2022)

Sacubitril/valsartan averts post-myocardial infarction ventricular remodeling and preserves heart function
por: Hajra, Adrija, et al.
Publicado: (2019)

Recovery of complete left bundle branch block in a dilated cardiomyopathy patient after treatment with sacubitril/valsartan: A case report
por: Peng, Meng-Ling, et al.
Publicado: (2022)

Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan
por: Correale, Michele, et al.
Publicado: (2023)

Ventricular arrhythmias in nonischemic cardiomyopathy: Overview
por: Kusano, Kengo
Publicado: (2018)

Sacubitril/valsartan in the treatment of systemic right ventricular failure
por: Zandstra, Tjitske E, et al.
Publicado: (2021)

A narrative review on sacubitril/valsartan and ventricular arrhythmias
por: Wei, Zhaoyang, et al.
Publicado: (2022)

Beneficial effects of one-month sacubitril/valsartan treatment in a patient affected by end-stage dystrophinopathic cardiomyopathy
por: Papa, Andrea Antonio, et al.
Publicado: (2020)

Sacubitril/Valsartan Conundrum
por: Somberg, John
Publicado: (2021)

Left ventricular output indices and sacubitril/valsartan titration: role of stroke volume index
por: Tolomeo, Paolo, et al.
Publicado: (2022)

CD34(+) Cell Transplantation Improves Right Ventricular Function in Patients with Nonischemic Dilated Cardiomyopathy
por: Frljak, Sabina, et al.
Publicado: (2018)

Eligibility and Usage of Sacubitril/Valsartan in Korea
por: Kim, Jin-Jin, et al.
Publicado: (2019)

Left Ventricular Geometry and Replacement Fibrosis Detected by cMRI Are Associated with Major Adverse Cardiovascular Events in Nonischemic Dilated Cardiomyopathy
por: Cojan-Minzat, Bianca Olivia, et al.
Publicado: (2020)

Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy
por: Okubo, Kenji, et al.
Publicado: (2018)

Modification of ventriculo–arterial coupling by spironolactone in nonischemic dilated cardiomyopathy
por: Lawson, Mark A., et al.
Publicado: (2021)

Serum albumin and prognosis in elderly patients with nonischemic dilated cardiomyopathy
por: Li, Xinyi, et al.
Publicado: (2023)

Association Between Left Ventricular Mechanical Deformation and Myocardial Fibrosis in Nonischemic Cardiomyopathy
por: Csecs, Ibolya, et al.
Publicado: (2020)

Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin–Angiotensin–Aldosterone System
por: Simko, Fedor, et al.
Publicado: (2022)

Use of sacubitril/valsartan in non‐compaction cardiomyopathy: a case report
por: Bonatto, Marcely Gimenes, et al.
Publicado: (2020)

Sacubitril/valsartan attenuates atrial structural remodelling in atrial fibrillation patients
por: Yang, Liu, et al.
Publicado: (2022)

Reverse remodelling by sacubitril/valsartan predicts the prognosis in heart failure with reduced ejection fraction
por: Moon, Mi‐Gil, et al.
Publicado: (2021)

Electrical Ventricular Remodeling in Dilated Cardiomyopathy
por: Mages, Christine, et al.
Publicado: (2021)

Ivabradine Improves Heart Rate Variability in Patients with Nonischemic Dilated Cardiomyopathy
por: Kurtoglu, Ertugrul, et al.
Publicado: (2014)

Effect of sacubitril/valsartan on investigator‐reported ventricular arrhythmias in PARADIGM‐HF
por: Curtain, James P., et al.
Publicado: (2022)

A case series about the favorable effects of sacubitril/valsartan on anthracycline cardiomyopathy
por: De Vecchis, Renato, et al.
Publicado: (2020)

Use of sacubitril/valsartan in Marfan syndrome–related cardiomyopathy: The first case report
por: Spoto, Silvia, et al.
Publicado: (2019)

Comparative and Combinatorial Effects of Resveratrol and Sacubitril/Valsartan alongside Valsartan on Cardiac Remodeling and Dysfunction in MI-Induced Rats
por: Raj, Pema, et al.
Publicado: (2021)

Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach
por: Iborra-Egea, Oriol, et al.
Publicado: (2017)

Implication of low dose sacubitril/valsartan
por: Imamura, Teruhiko
Publicado: (2021)

Effects and clinical implications of sacubitril/valsartan on left ventricular reverse remodeling in patients affected by chronic heart failure: A 24-month follow-up
por: Paolini, Carla, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pgik2vb110664pikuoa5a9tk02